June 24, 2021 | LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing … Continue reading UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer